Clinical trial
Phase II Study of VCD/IE in the Treatment of the Patients With Ewing's Sarcoma Family of Tumors
NCT00568464 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of VCD/IE in the Treatment of the Patients With Ewing's Sarcoma Family of Tumors
- Lead sponsor
- Fudan University
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 31, 2007
- Completion date
- September 30, 2009
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ewing's sarcoma